Drugs / Immunoglobulin Anti-RhD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01666249 | Apr → Nov 2014 | Rh isoimmunization | Azidus Brasil | Suspended | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Immunoglobulin Anti-RhD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01666249 ↗ |
| Action | Inhibit | “"neutralizes" D antigen present in the Rh-positive fetal red blood cells (Rh +)” NCT01666249 ↗ |
| Modality | Protein / enzyme biologic | “The anti-Rh immunoglobulin is an immunobiological containing high concentration of specific antibodies against factor D” NCT01666249 ↗ |
| Route | Intramuscular | “single intramuscular administration” NCT01666249 ↗ |